Adalta

Adalta Inventory

The Inventory of Adalta (1AD.AX) as of Oct 21, 2026 is -1.95 M AUD. In the previous year, Inventory was -2.49 M AUD — a change of -21.65% (higher).

Inventory

-1.95 MAUD

YoY

-21.65%

Last updated:

Inventory of Adalta is 2024 -1.95 M AUD. Inventory of Adalta was 2023 -2.49 M AUD. It decreases by -21.65% higher compared to the previous year.

The Adalta Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2017
-1.84 M AUD
Jan 1, 2018
-2.08 M AUD
Jan 1, 2019
-3.58 M AUD
Jan 1, 2020
-3.31 M AUD
Jan 1, 2021
-2.98 M AUD
Jan 1, 2022
1.00 AUD
Jan 1, 2023
-2.49 M AUD
Jan 1, 2024
-1.95 M AUD
The Adalta Inventory history
YEARInventoryYoY
-1.95 MAUD-21.65%
-2.49 MAUD-249.02 M%
1.00AUD-100.00%
-2.98 MAUD-10.08%
-3.31 MAUD-7.45%
-3.58 MAUD+71.94%
-2.08 MAUD+13.11%
-1.84 MAUD+1,265.47%
-134,714.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Adalta Stock analysis

What does Adalta do? AdAlta Ltd. operates as a biotechnology company that discovers, develops, and commercializes protein based therapeutics. The firm is engaged in the development of therapeutic products from its i-body platform. The firm has five active development programs ranging from discovery to Phase II clinical trials with applications in the fields of inflammation/fibrosis and immuno-oncology. Its lead product, AD-214, is an antibody therapeutic for the treatment of fibrotic diseases, including lung fibrosis (specifically Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD)), kidney fibrosis, eye fibrosis and some cancers. Chimeric Antigen Receptor (CAR) cell therapies involve modification of a patient’s immune cells (T cells, NK cells, macrophages and other) so that they produce a CAR on the cell surface that enables the patient’s immune system to recognize and kill diseased cells such as cancer. The company develops i-body enabled PET (i-PET) imaging agents for use in immuno-oncology. The company evaluates several CXCR4 i-bodies. Adalta is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Adalta stock

Inventory of Adalta is -1.95 M AUD in 2024.

Inventory of Adalta changed from -2.49 M AUD to -1.95 M AUD, representing a -21.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Adalta since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Adalta historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Adalta

All Key Metrics — Adalta